View Document Preview and Link Document Date: 2013-09-12 05:44:27 Open Document File Size: 60,43 KB Share Result on Facebook
City New York / / Company Immtech Pharmaceuticals Inc / / Country United States / Angola / Sudan / / Event FDA Phase / / Facility Swiss Tropical Institute / University of North Carolina / Chapel Hill / / IndustryTerm treatment of the disease / / MedicalCondition disease / human African trypanosomiasis / African sleeping sickness / Sickness / / NaturalFeature Chapel Hill / / Organization Swiss Center for International Health / Melinda Gates Foundation / United States Food & Drug Administration / University of North Carolina / Chapel Hill / Swiss Tropical Institute / / Product Pafuramidine Maleate / / ProvinceOrState North Carolina / New York / / SocialTag 
Welcome to the STI - SCIH Newsletter! Target patient enrollment number in Phase III Trial of Pafuramidine Maleate (DB289) in Treatment of Sleeping Sickness reached We are very pleased to announce that the targ